Services: Diversified Services

Genetic Technologies Ltd (GENE: NASDAQ)

$1.4899 -0.0201 | -1.33%
10/26/16 - 03:58 PM ET
Company Cash Flow
Jun 2016 Jun 2015 Jun 2014 Jun 2013
Cash Flow From Operating Activities
Net Income (Loss) 0.00 -6.76M -9.54M -8.68M
Operating Gains/Losses n.a. -1.34M 182.50K 405.49K
Extraordinary Gains / Losses n.a. 0.00 0.00 0.00
(Increase) Decrease In Receivables n.a. 116.85K -737.12K 155.27K
(Increase) Decrease in Inventories n.a. 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets n.a. -491.00 194.27K -178.00K
(Decrease) Increase In Payables n.a. -316.20K 69.34K 435.89K
(Decrease) Increase In Other Current Liabilities 0.00 80.94K -221.81K 14.83K
(Increase) Decrease In Other Working Capital n.a. 591.77K -748.99K 50.23K
Other Non-Cash Items -5.77M 254.55K 156.17K 319.28K
Net Cash From Continuing Operations -5.77M -7.43M -10.34M -6.97M
Net Cash From Discontinued Operations n.a. 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -5.77M -7.43M -10.34M -6.97M
Sale of Property, Plant & Equipment 5.33K 43.81K 0.00 1.11K
Cash Used for Investing Activities
Sale of Short-Term Investments n.a. 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -226.62K -147.72K -45.11K -49.74K
Acquisitions 0.00 1.61M 0.00 -117.14K
Purchases of Short-Term Investments n.a. 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 0.00 -172.34K 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -221.29K 1.51M 218.78K -165.77K
Issuance of Debt 0.00 1.65M 5.25M 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 0.00 17.86M 6.59M 446.78K
Repayment of Long-Term Debt 0.00 0.00 0.00 -16.47K
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -1.24K -1.97M -619.97K -23.94K
Net Cash From Financing Activities -1.24K 17.54M 11.23M 406.38K
Effect of Exchange Rate Changes 644.59K 283.11K -55.04K 72.87K
Net Change in Cash & Cash Equivalents -5.35M 11.90M 1.04M -6.66M

Portfolios with GENE

Latest GENE Headlines from TheStreet

More Financial News for GENE

Press Releases for GENE

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter